Your browser doesn't support javascript.
loading
Liver chemoembolization of hepatocellular carcinoma using TANDEM® microspheres.
Delicque, Julien; Guiu, Boris; Boulin, Mathieu; Schwanz, Heidi; Piron, Lauranne; Cassinotto, Christophe.
Afiliação
  • Delicque J; Department of Radiology, St-Eloi University Hospital, 34980 Montpellier, France.
  • Guiu B; Department of Radiology, St-Eloi University Hospital, 34980 Montpellier, France.
  • Boulin M; INSERM U1194, Montpellier Cancer Research Institute, 34298 Montpellier, France.
  • Schwanz H; Department of Pharmacy, University Hospital of Dijon, 21000 Dijon, France.
  • Piron L; Boston Scientific, Maple Grove, MN 55311, USA.
  • Cassinotto C; Department of Radiology, St-Eloi University Hospital, 34980 Montpellier, France.
Future Oncol ; 14(26): 2761-2772, 2018 Nov.
Article em En | MEDLINE | ID: mdl-29953255
ABSTRACT
Transarterial chemoembolization (TACE) combines intra-arterial delivery of a chemotherapeutic agent with selective embolization to obtain a synergistic effect. TACE is recognized as the standard treatment of hepatocellular carcinoma patients at an intermediate stage. If conventional TACE, defined as the injection of an emulsion of a drug with ethiodized oil, still has a role to play, the development of drug-eluting beads has allowed many improvements and optimization of the technique. TANDEM® microspheres are second-generation drug-loadable microspheres. This device raised a special interest due to its tightly calibrated spherical microspheres, with small sizes down to 40 µm available. In this review, we describe the technical characteristics of these microspheres, analyze the scientific literature and hypothesize on the future perspectives.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Future Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioembolização Terapêutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Future Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França